Zobrazeno 1 - 10
of 7 469
pro vyhledávání: '"Kuykendall, A."'
Autor:
Çiğdem Ak, Zeynep Sayar, Guillaume Thibault, Erik A. Burlingame, M.J. Kuykendall, Jennifer Eng, Alex Chitsazan, Koei Chin, Andrew C. Adey, Christopher Boniface, Paul T. Spellman, George V. Thomas, Ryan P. Kopp, Emek Demir, Young Hwan Chang, Vasilis Stavrinides, Sebnem Ece Eksi
Publikováno v:
iScience, Vol 27, Iss 9, Pp 110668- (2024)
Summary: Mapping the spatial interactions of cancer, immune, and stromal cell states presents novel opportunities for patient stratification and for advancing immunotherapy. While single-cell studies revealed significant molecular heterogeneity in pr
Externí odkaz:
https://doaj.org/article/af29b6f146c548339d8565cc10e61ec6
Autor:
Ak, Çiğdem, Sayar, Zeynep, Thibault, Guillaume, Burlingame, Erik A., Kuykendall, M.J., Eng, Jennifer, Chitsazan, Alex, Chin, Koei, Adey, Andrew C., Boniface, Christopher, Spellman, Paul T., Thomas, George V., Kopp, Ryan P., Demir, Emek, Chang, Young Hwan, Stavrinides, Vasilis, Eksi, Sebnem Ece
Publikováno v:
In iScience 20 September 2024 27(9)
Publikováno v:
In Clinical Lymphoma, Myeloma and Leukemia August 2024 24(8):512-522
Autor:
Aguirre, Luis E., Jain, Akriti, Ball, Somedeb, Ali, Najla Al, Volpe, Virginia O., Tinsley-Vance, Sara, Sallman, David, Sweet, Kendra, Lancet, Jeffrey, Padron, Eric, Yun, Seongseok, Kuykendall, Andrew, Komrokji, Rami
Publikováno v:
In Clinical Lymphoma, Myeloma and Leukemia July 2024 24(7):459-467
Autor:
Ionescu, Filip, David, Jerel C., Ravichandran, Apoorva, Sallman, David A., Sweet, Kendra, Komrokji, Rami S., Chan, Onyee, Kuykendall, Andrew, Padron, Eric, Faramand, Rawan, Bejanyan, Nelli, Khimani, Farhad, Elmariah, Hany, Pidala, Joseph, Mishra, Asmita, Perez, Lia, Nishihori, Taiga, Lancet, Jeffrey E.
Publikováno v:
In Clinical Lymphoma, Myeloma and Leukemia June 2024 24(6):400-406
Autor:
Akriti G. Jain, Somedeb Ball, Luis Aguirre, Najla Al Ali, David Kaldas, Sara Tinsley-Vance, Andrew Kuykendall, Onyee Chan, Kendra Sweet, Jeffrey E. Lancet, Eric Padron, David A. Sallman, Rami Komrokji
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
The patterns of low risk myelodysplastic syndrome (MDS) progression, and the clinical and molecular features of those patterns are not well described. We divided our low risk (LR) MDS patients (n=1914) into 4 cohorts: 1) Patients who remained LR-MDS
Externí odkaz:
https://doaj.org/article/8c6b1ac7b01a432c91e1cb0cd4fc8575
Autor:
Pankit Vachhani, John Mascarenhas, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M. Palmer, Aaron T. Gerds, Lucia Masarova, Andrew T. Kuykendall, Raajit K. Rampal, Ruben Mesa, Srdan Verstovsek
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Interferons are cytokines with immunomodulatory properties and disease-modifying effects that have been used to treat myeloproliferative neoplasms (MPNs) for more than 35 years. The initial use of interferons was limited due to difficulties with admi
Externí odkaz:
https://doaj.org/article/f914014456cf435ebd924c6e619ff22a
Autor:
Tejas Patil, MD, Alyse Staley, MS, Yunan Nie, MD, Mandy Sakamoto, MD, Margaret Stalker, MD, James M. Jurica, MD, MBA, Kenna Koehler, BA, Amanda Cass, PharmD, Halle Kuykendall, BA, Emily Schmitt, MS, Emma Filar, BA, Evelina Reventaite, MS, Kurt D. Davies, PhD, Hala Nijmeh, PhD, Mary Haag, PhD, Benjamin A. Yoder, PharmD, Paul A. Bunn, MD, Erin L. Schenk, MD, PhD, Dara L. Aisner, MD, PhD, Wade T. Iams, MD, Melina E. Marmarelis, MD, D. Ross Camidge, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 2, Pp 100637- (2024)
Introduction: Acquired MET gene amplification, MET exon 14 skip mutations, or MET fusions can emerge as resistance mechanisms to tyrosine kinase inhibitors (TKIs) in patients with lung cancer. The efficacy and safety of combining MET TKIs (such as cr
Externí odkaz:
https://doaj.org/article/63d7bcf67c604305b7273bb565a9b37b
Autor:
Barbara Mora, Margherita Maffioli, Elisa Rumi, Paola Guglielmelli, Marianna Caramella, Andrew Kuykendall, Francesca Palandri, Alessandra Iurlo, Valerio De Stefano, Jean‐Jacques Kiladjian, Elena M. Elli, Nicola Polverelli, Jason Gotlib, Francesco Albano, Richard T. Silver, Giulia Benevolo, David M. Ross, Timothy Devos, Oscar Borsani, Tiziano Barbui, Matteo G. Della Porta, Lorenza Bertù, Rami Komrokji, Alessandro M. Vannucchi, Francesco Passamonti
Publikováno v:
eJHaem, Vol 4, Iss 3, Pp 679-689 (2023)
Abstract Myelofibrosis (MF) is a clonal malignancy frequently characterized by anemia and in 10%–20% of cases it can evolve into blast phase (BP). Anemia in MF is associated with reduced survival and ‐in primary MF‐ also with an increased proba
Externí odkaz:
https://doaj.org/article/26a6053aeda245cdaafd073cb35b9304
Autor:
Chan, Onyee, Al Ali, Najla, Tashkandi, Hammad, Ellis, Austin, Ball, Somedeb, Grenet, Justin, Hana, Caroline, Deutsch, Yehuda, Zhang, Ling, Hussaini, Mohammad, Song, Jinming, Yun, Seongseok, Talati, Chetasi, Kuykendall, Andrew, Padron, Eric, Walker, Alison, Roboz, Gail, Desai, Pinkal, Sallman, David, Sweet, Kendra, Komrokji, Rami, Lancet, Jeffrey
Publikováno v:
In Blood Advances 12 March 2024 8(5):1075-1083